These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9636613)

  • 21. An investigation of the pharmacokinetics, toxicity, and clinical efficacy of Neoral cyclosporin in cystic fibrosis patients.
    Mikhail G; Eadon H; Leaver N; Rogers P; Stephens D; Banner N; Khaghani A; Yacoub M
    Transplant Proc; 1997; 29(1-2):599-601. PubMed ID: 9123148
    [No Abstract]   [Full Text] [Related]  

  • 22. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advantage--FK 506: reduced chronic rejection for lung transplant recipients.
    Bolman RM
    Ann Thorac Surg; 1995 Sep; 60(3):495-6. PubMed ID: 7545888
    [No Abstract]   [Full Text] [Related]  

  • 24. Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation.
    Fieguth HG; Krueger S; Wiedenmann DE; Otterbach I; Wagner TO
    Transplant Proc; 2002 Aug; 34(5):1884. PubMed ID: 12176613
    [No Abstract]   [Full Text] [Related]  

  • 25. Survival after bronchiolitis obliterans syndrome.
    Yerkovich ST; Hopkins PM; Chambers DC
    Am J Respir Crit Care Med; 2011 Feb; 183(4):554; author reply 554-5. PubMed ID: 21325085
    [No Abstract]   [Full Text] [Related]  

  • 26. [Graft dysfunction, acute rejection and bronchiolitis obliterans in lung and heart-lung transplantation].
    Sleiman C; Groussard O; Mal H; Fournier M
    Rev Mal Respir; 1996 Nov; 13(5 Suppl):S31-40. PubMed ID: 9011909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FK506 "rescue" therapy complicated by renal tubular acidosis in renal allograft recipients.
    Goh BL; Tan SY
    Transplant Proc; 1998 Nov; 30(7):3594-5. PubMed ID: 9838575
    [No Abstract]   [Full Text] [Related]  

  • 28. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
    Hachem RR; Yusen RD; Chakinala MM; Meyers BF; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2007 Oct; 26(10):1012-8. PubMed ID: 17919621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation.
    Bhorade S; Ahya VN; Baz MA; Valentine VG; Arcasoy SM; Love RB; Seethamraju H; Alex CG; Bag R; Deoliveira NC; Husain A; Vigneswaran WT; Charbeneau J; Krishnan JA; Durazo-Arvizu R; Norwick L; Garrity E
    Am J Respir Crit Care Med; 2011 Feb; 183(3):379-87. PubMed ID: 20833822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases.
    Taibi A; Adham M; Ducerf C; Chevallier M; Bizollon T; Delaroche E; Aljuaid N; Berthoux N; Baulieux J
    Transplant Proc; 1998 Jun; 30(4):1411-2. PubMed ID: 9636571
    [No Abstract]   [Full Text] [Related]  

  • 31. Experience with cyclosporine in living-donor lobar lung transplantation.
    Date H
    Transplant Proc; 2004 Mar; 36(2 Suppl):349S-351S. PubMed ID: 15041366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus (FK506) as primary immunosuppressant after lung transplantation.
    Kur F; Reichenspurner H; Meiser BM; Welz A; Fürst H; Müller C; Vogelmeier C; Schwaiblmaier M; Briegel J; Reichart B
    Thorac Cardiovasc Surg; 1999 Jun; 47(3):174-8. PubMed ID: 10443520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation.
    Zuckermann A; Birsan T; Thaghavi S; Kupilik N; Deviatko E; Dekan G; Wolner E; Klepetko W
    Transplant Proc; 1999; 31(1-2):1160-1. PubMed ID: 10083518
    [No Abstract]   [Full Text] [Related]  

  • 34. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.
    Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465
    [No Abstract]   [Full Text] [Related]  

  • 35. Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine.
    Izbicki G; Shitrit D; Aravot D; Sulkes J; Saute M; Sahar G; Kramer MR
    Transplant Proc; 2002 Dec; 34(8):3258-9. PubMed ID: 12493439
    [No Abstract]   [Full Text] [Related]  

  • 36. Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study.
    Woeste G; Wullstein C; Dette K; Pridöhl O; Lübke P; Bechstein WO
    Transplant Proc; 2002 Aug; 34(5):1920-1. PubMed ID: 12176629
    [No Abstract]   [Full Text] [Related]  

  • 37. Behavior of International Society for Heart and Lung Transplantation grade 2 cardiac rejection.
    Milano A; Livi U; Caforio AL; Bianco R; Casula R; Gambino A; Feltrin G; Legittimo A; Angelini A; Thiene G
    Transplant Proc; 1994 Oct; 26(5):2724. PubMed ID: 7940853
    [No Abstract]   [Full Text] [Related]  

  • 38. Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome.
    Cairn J; Yek T; Banner NR; Khaghani A; Hodson ME; Yacoub M
    J Heart Lung Transplant; 2003 Jan; 22(1):50-7. PubMed ID: 12531413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aerosolized cyclosporine in lung recipients with refractory chronic rejection.
    Iacono AT; Keenan RJ; Duncan SR; Smaldone GC; Dauber JH; Paradis IL; Ohori NP; Grgurich WF; Burckart GJ; Zeevi A; Delgado E; O'Riordan TG; Zendarsky MM; Yousem SA; Griffith BP
    Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1451-5. PubMed ID: 8616581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FK 506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation.
    Ross DJ; Lewis MI; Kramer M; Vo A; Kass RM
    Chest; 1997 Nov; 112(5):1175-9. PubMed ID: 9367453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.